KAIROS PHARMA, LTD.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $437.0K |
| FY2023 | $3.0M | $965.0K | $93.0K |
| FY2024 | $992.0K | $5.8M | $1.3M |
| FY2025 | $199.0K | $6.5M | $4.5M |
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2022 | — | — | $437.0K |
| FY2023 | $3.0M | $965.0K | $93.0K |
| FY2024 | $992.0K | $5.8M | $1.3M |
| FY2025 | $199.0K | $6.5M | $4.5M |